International Conference on Rheumatology and Translational Research
IC-RTR
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This session will explore the latest innovations in molecular diagnostics that enhance the understanding and management of rheumatic diseases. Emphasis will be placed on the integration of genomic and proteomic technologies in clinical practice.
SDG 3
SDG 4
This track focuses on the translation of basic scientific discoveries into clinical applications for autoimmune rheumatic diseases. Participants will discuss recent breakthroughs and their implications for patient care and treatment strategies.
SDG 3
SDG 9
This session will highlight novel therapeutic approaches and interventions in the management of rheumatic diseases. Discussions will include targeted therapies, biologics, and personalized medicine.
SDG 3
SDG 9
This track will address the methodologies and challenges associated with designing and conducting clinical trials in rheumatology. Key topics will include patient recruitment, outcome measures, and regulatory considerations.
SDG 3
SDG 4
This session will delve into the immunological underpinnings of various rheumatic conditions. Presentations will cover the role of immune cells, cytokines, and signaling pathways in disease pathogenesis.
SDG 3
SDG 9
This track will focus on the identification and validation of biomarkers for rheumatic diseases, aiming to improve diagnostic accuracy and treatment monitoring. Participants will share insights on the latest research and clinical applications.
SDG 3
SDG 9
This session will emphasize the importance of patient-centered approaches in the management of rheumatic diseases. Discussions will include shared decision-making, patient education, and quality of life assessments.
SDG 3
SDG 10
This track will showcase cutting-edge laboratory techniques and technologies that are transforming rheumatology research and diagnostics. Topics will include high-throughput screening, imaging technologies, and bioinformatics.
SDG 3
SDG 9
This session will investigate the complex biological mechanisms underlying rheumatic diseases. Presentations will focus on cellular and molecular pathways that contribute to disease progression and severity.
SDG 3
SDG 9
This track will explore integrative and holistic approaches to managing rheumatic diseases, including complementary therapies and lifestyle interventions. The session aims to discuss the evidence supporting these strategies and their impact on patient outcomes.
SDG 3
SDG 10
This session will provide insights into emerging trends and future directions in rheumatology research. Participants will discuss the potential impact of new technologies and interdisciplinary collaborations on advancing the field.
SDG 3
SDG 9